SCHEMBL27365320

SCHEMBL27365320

CCC(=O)/C(C#N)=C/CC(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15607 0.80 GRIK1 (0.42) GRIK1
SCHEMBL13993014 0.80 GRIK1 (0.34) GRIK1CYP2C9
SCHEMBL15606 0.80 GRIK1 (0.42) GRIK1
SCHEMBL7563918 0.80 GRIK1 (0.42) GRIK1
SCHEMBL28312635 0.78 EGFR (0.41) GRIK1CYP2C9
SCHEMBL15804833 0.77
SCHEMBL19300296 0.77
SCHEMBL1419493 0.77 CYP2C9 (0.56) CYP2C9
SCHEMBL1419495 0.77 CYP2C9 (0.56) CYP2C9
SCHEMBL20016033 0.76 CYP2C9 (0.34) CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024057021-A1 COMPOUNDS FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2024-03-21 WO disclosed